SCHEMBL6317536

SCHEMBL6317536

Cc1cc2c(OCC3CO3)cccc2o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
GLA P06280 1/20 0.56
TP53 P04637 3/20 0.47
TSHR P16473 3/20 0.47
HIF1A Q16665 2/20 0.47
CYP3A4 P08684 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.41
HTR1A P08908 4/20 0.39
CYP2A6 P11509 2/20 0.38
CCR1 P32246 1/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.37
PPARG P37231 1/20 0.37
PKM P14618 1/20 0.35
VDR P11473 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5432111 1.00 ALDH1A1 (0.56) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584409 0.81 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584167 0.80 ALDH1A1 (0.47) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL9588603 0.80 ALDH1A1 (0.47) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584668 0.80 ALDH1A1 (0.47) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584799 0.79 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5585018 0.79 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584429 0.79 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584474 0.79 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL5584901 0.79 TDP1 (0.45) ALDH1A1GLATP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844344-B2 Benzofuran derivatives ELI LILLY AND COMPANY (US) 2005-01-18 US disclosed
US-20030232833-A1 Benzofuran derivatives ELI LILLY AND COMPANY 2003-12-18 US disclosed
EP-1246822-A1 BENZOFURAN DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001046177-A1 BENZOFURAN DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232833-A1 Benzofuran derivatives BRD1, BPTF, HTR1F ALDH1A1 90/4885GLA 1198/4885TP53 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.